¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Annals of Hepatology

Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), Science Citation Index Expanded (SCIE), SCImago Journal Rank (SJR), SNIP

See more

Follow us

X Facebook

Alert

Newsletter

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2024

4.4

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2025

9.6

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2025

1.446

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2025

1.378

Time to first decision

The median number of days it takes for an article to go from submission to first editorial decision.

See more

Time to first decision

8 days

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Cover Vol. 31. Issue 2. (In progress)

Vol. 31. Issue 2. (In progress)

(July - December 2026)

This issue is in progress but contains articles that are final and fully citable.

Editorial

Cirrhotic cardiomyopathy impact goes global! The South American experience

Murray Coetzee, Manhal Izzy

Ann Hepatol. 2026;31: 102202

Full text access

Share

Making metabolic dysfunction-associated steatotic liver disease medicines affordable: Lessons from hepatitis C

Khalid M. AlNaamani, Mohamed El-Kassas, Zobair M. Younossi

Ann Hepatol. 2026;31: 102213

Full text access

Share

Opinions

Alarming increase of acute liver failure during Sudan’s conflict: a call for urgent global hepatology response

Mumen Abdalazim Dafallah, Manasik Mamoun

Ann Hepatol. 2026;31: 102167

Full text access

Share

Original articles

Is FIB-4 the right tool for screening for liver fibrosis?

Leen J.M. Heyens, Demi P.A. van Malde, Gediz Dogay Us, Francesco Innocenti, Mathieu Struyve, Christophe Van Steenkiste, Sven Francque, Geert Robaeys, ... the MASLD research group

Ann Hepatol. 2026;31: 102176

Full text access

Share

Liver transplant outcomes of deceased donor types following normothermic machine perfusion: A meta-analysis

Abraham M.P. den Dekker, Alexander Franssen, Ewout W. Steyerberg, Hwai-Ding Lam, Jason B. Doppenberg, Ian P.J. Alwayn

Ann Hepatol. 2026;31: 102187

Full text access

Share

Situational panorama of chronic liver diseases: A single-center experience at a university hospital in northeast Mexico (1995–2019)

Paula Cordero-Perez, Liliana Torres-González, Samuel Rivas-López, Carolina Treviño-García, Airam Regalado-Ceballos, Jaime R. Zúñiga-Noriega, Ingrid G. López-Reyna, Luz M. Barbosa-Castillo, ... Linda E. Muñoz-Espinosa

Ann Hepatol. 2026;31: 102116

Full text access

Share

Clinical, etiological, and demographic aspects of cirrhosis in South America: a report from the South American Liver Research Network

Jhon E. Prieto, Diego R. Puentes, Angelo Z. Mattos, Enrique Carrera E., Javier Diaz Ferrer, Martín Padilla-Machaca, Domingo Balderramo, Manuel Mendizabal, ... José D. Debes

Ann Hepatol. 2026;31: 102186

Full text access

Share

Twofold increased risk of coronary artery disease after liver transplantation: A nationwide Swedish cohort of 2925 patients

Christian Lewinter, Linnea Widman, Michael Melin, Axel Wester, Ying Shang, Hannes Hagström

Ann Hepatol. 2026;31: 102172

Full text access

Share

Clostridium butyricum reduces the incidence of overt hepatic encephalopathy in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt (TIPS)

Xiaotong Xu, Tong Zhu, Changyou Jing, Kunlei Zhu, Qinghua Meng, Jianjun Li

Ann Hepatol. 2026;31: 102185

Full text access

Share

Liver transplant outcomes in primary biliary cholangitis and metabolic dysfunction-associated steatotic liver disease overlap

Leandro Sierra, Shahana Prakash, Jamak Modaresi Esfeh, Omar T. Sims, Dian J. Chiang

Ann Hepatol. 2026;31: 102201

Full text access

Share

Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among primary care providers in the four most populous U.S. cities

Jeffrey V. Lazarus, Trenton M. White, Melina I. Manolas, Alina M. Allen, Silvana Pannain, Naim Alkhouri, Meena B. Bansal, Michael Charlton, ... Ayman El-Mohandes

Ann Hepatol. 2026;31: 102200

Full text access

Share

Can liver biopsy be spared for the diagnosis of autoimmune hepatitis in selected children? A multicenter retrospective study

Valeria Delle Cave, Fabiola Di Dato, Pier Luigi Calvo, Michele Pinon, Marina Aloi, Francesca Zucconi, Ruggiero Francavilla, Eugenia Rizzitelli, ... Raffaele Iorio

Ann Hepatol. 2026;31: 102198

Full text access

Share

Optimal screening criteria for metabolic dysfunction-associated steatotic liver disease with fibrosis

Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Dong Hyun Sinn

Ann Hepatol. 2026;31: 102199

Full text access

Share

Association of nonselective β blockers with the development of hepatocellular carcinoma in liver cirrhosis: a meta-analysis

Yan Xu, Xiaohe Wang, Xiangdong Li, Qingchun Zhao, Xiangbo Xu

Ann Hepatol. 2026;31: 102173

Full text access

Share

Relationship between sleep patterns and incident liver related events: retrospective analysis of prospectively collected data from UK Biobank participants

Xiangxia Zeng, Shijia Wang, Peiting Zhang, Ailan Chen, Hongliang Xue

Ann Hepatol. 2026;31: 102151

Full text access

Share

The association of frailty with cardiovascular diseases and mortality in metabolic dysfunction-associated steatotic liver disease

Fuyi Ma, Huanyu Wang, Kang Wan, Yuan Li, Yuhang Chen, Ru Wang

Ann Hepatol. 2026;31: 102214

Full text access

Share

Clinical practice guidelines

ALEH position statement on the management of hepatitis B virus infection 2025

Mario Guimarães Pessoa, Nelia Hernandez, Graciela Castro Narro, Angelo A. Mattos, Marcelo Silva, Alejandro Soza, Lucy Dagher, Martin Padilla-Machaca, ... Latin American Association for the Study of the Liver (ALEH)

Ann Hepatol. 2026;31: 102192

Full text access

Share

Brief report

Adult-to-adult living donor liver transplantation in a low-middle income country setting: eight-year experience from Colombia’s first program

Gilberto Mejía, Nathaly Ramírez, Carlos Benavides, Jairo Rivera, María Camila Álvarez, Ana María Martínez, Juan Manuel Pérez, Isabel Quiroga, ... Luis Manuel Barrera-Lozano

Ann Hepatol. 2026;31: 102193

Full text access

Share

Acute-on-chronic liver failure designation in patients with severe alcohol-associated hepatitis undergoing liver transplantation

Kevin Houston, Hiba Khan, Hasan Alroobi, Niki Wadhwa, Nikita Chadha, Chad Spencer, Amon Asgharpour, Nicole Keller, ... Richard K. Sterling

Ann Hepatol. 2026;31: 102190

Full text access

Share

Letters to the editor

Reply to: Comment on “pancreatic involvement and its prognostic impact in acute-on chronic liver failure”

Georg Kramer, Thomas Reiberger

Ann Hepatol. 2026;31: 102194

Full text access

Share

Sarcopenia risk in liver transplant candidates: Should artificial intelligence-based body composition analysis be incorporated into pre-transplant assessment?

Jianhao Zhang, Zipei Wang, Guobin Huang, Xuechun Zhao, Bo Yang

Ann Hepatol. 2026;31: 102210

Full text access

Share

Long-term antiviral therapy sustains HBsAg decline, increases HBV RNA negativity and enhances the proportion of patients achieving functional cure in chronic hepatitis B

Ruihan Gao, Shuting Liu, Shiyu Zhang, Xin Zhou, Bin Zhu, Baoju Wang

Ann Hepatol. 2026;31: 102212

Full text access

Share

Publish in

Annals of Hepatology

Affiliated societies